粗鄙的人 发表于 2025-3-25 03:55:42
1064-3745expertsThis detailed volume explores numerous methods used in basic science laboratories to characterize cancer-related biomarkers, vital for better managing cancer burden, including cancer risk assessment, cancer diagnosis, determining cancer progression, and therapeutic response. From a radiograp内行 发表于 2025-3-25 07:49:49
http://reply.papertrans.cn/23/2211/221049/221049_22.pngarcane 发表于 2025-3-25 14:36:19
http://reply.papertrans.cn/23/2211/221049/221049_23.pngchiropractor 发表于 2025-3-25 19:06:15
http://reply.papertrans.cn/23/2211/221049/221049_24.png敲竹杠 发表于 2025-3-25 23:29:45
https://doi.org/10.1007/978-3-642-83311-3ve the potential to function as biomarkers for early diagnosis and treatment measurements as well as research. This chapter reviews both established and evolving PET radiotracers used to image tumor biology. We have also included a few advantages and disadvantages of the routinely used PET radiotracers in cancer imaging.过滤 发表于 2025-3-26 03:32:13
http://reply.papertrans.cn/23/2211/221049/221049_26.png无畏 发表于 2025-3-26 06:55:26
https://doi.org/10.1007/978-3-642-83311-3 suitable for small molecule drug screening in high-throughput setting, easy maintenance, transparency for easy observation, high fecundity, and rapid generation time. The zebrafish model is a good alternative in vivo model to mammals for robust testing of drug candidates for cancer therapy.是剥皮 发表于 2025-3-26 10:54:54
http://reply.papertrans.cn/23/2211/221049/221049_28.png证明无罪 发表于 2025-3-26 15:02:11
PET Use in Cancer Diagnosis, Treatment, and Prognosis,ve the potential to function as biomarkers for early diagnosis and treatment measurements as well as research. This chapter reviews both established and evolving PET radiotracers used to image tumor biology. We have also included a few advantages and disadvantages of the routinely used PET radiotracers in cancer imaging.moribund 发表于 2025-3-26 16:57:55
Immunofluorescence-Based Method to Assess Cancer Biomarker in the Hypoxic Region of the Tumor,nidazole for the identification of hypoxic regions in PCa xenograft tumors along with CPT1A (carnitine palmitoyltransferase 1A) expression, an indicator of β-oxidation. This approach could be useful to characterize various biomarkers in the complex hypoxic tumor microenvironment.